Grants and Contributions:
Title:
YOUTH Rapid Prophylaxis Development against COVID-19
Agreement Number:
952405
Agreement Value:
$30,000.00
Agreement Date:
Jun 15, 2020 - Mar 23, 2021
Description:
This project is to develop community-based prophylaxis for COVID-19 via our newly developed Angiotensin-Converting Enzyme 2 (ACE2) mimetics, and to develop marketing strategy for our innovative products.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP’s Youth Employment Program is to assist in increasing the supply of highly qualified people, promoting the benefits of advanced studies, demonstrating federal leadership by investing in the skills required to meet the needs of the knowledge economy and facilitating the transition of highly skilled young people to a rapidly changing labour market.
Location:
Toronto, Ontario, CA M5B 1T8
Reference Number:
172-2020-2021-Q1-952405
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
780647129
Recipient Type:
For-profit organization
Recipient's Operating Name:
CCOA Therapeutics Inc
Recipient's Legal Name:
CCOA Therapeutics Inc
Federal Riding Name:
Toronto Centre
Federal Riding Number:
35108
Program:
Industrial Research Assistance Program – Youth Employment Program
Program Purpose:
The purpose of IRAP’s Youth Employment Program is to assist in increasing the supply of highly qualified people, promoting the benefits of advanced studies, demonstrating federal leadership by investing in the skills required to meet the needs of the knowledge economy and facilitating the transition of highly skilled young people to a rapidly changing labour market.
Coverage:
IRAP Youth Employment Program projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
3254